Clinical Trial

EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures

Study acronym: ENDURE1
Recruiting
View on ClinicalTrials.gov →
Summary
The main objective of this clinical investigation is to assess the safety and feasibility of the Optilume DCB for treatment of ureteric strictures.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-06-04; most recent amendment 2026-03-06.
Status change: Not Yet Recruiting → Recruiting 2025-09-23
Trial Details
NCT Number NCT07020520
Lead Sponsor Urotronic Inc.
Collaborators: Laborie Medical Technologies Inc.
Conditions Ureteral Stricture
Enrollment 60 participants
Start Date 2025-10-01
Primary Completion 2027-02-28 (estimated)
Study Completion 2031-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-09